Mesoblast Ltd Files 6-K Report
Ticker: MEOBF · Form: 6-K · Filed: May 15, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
MESOBLAST LTD filed a 6-K report on 5/15/25, standard foreign issuer update.
AI Summary
On May 15, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of May 2025, indicating it is a report of a foreign private issuer. The company is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing provides an update on Mesoblast Limited's regulatory activities as a foreign private issuer, which may contain information relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- May 15, 2025 (date) — Filing date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this report filed?
This report was filed on May 15, 2025.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
What is attached to this Form 6-K filing?
A new release announcement filed by Mesoblast Limited with the Australian Securities Exchange on May 15, 2025, is attached as Exhibit 99.1.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 by Silviu Itescu regarding MESOBLAST LTD (MEOBF).